Clouds M Pharmaz Pvt. Ltd. (cMp) is one of the fastest growing & experienced marketing pharmaceutical companies in India with broad spectrum of products benefiting the Masses. It's also an ISO 9001:2015 certified company. Our I. Import-Export License Code is 2117501109.

cMp has a strong presence in states of Jammu&Kashmir, Punjab, Haryana, Delhi, Rajasthan, Gujarat, M.P., Bihar, Jharkhand, Chhattisgarh , Orissa, U.P., West Bengal, Maharashtra and North-East states with our own distribution channels. cMp group is led by a team of outstanding professionals of the healthcare industry whose unmatched expertise in their domains contributes significantly to our success. With active fieldwork, dedicated research and recognition of the efforts of those who work behind the scenes to combat illness and disease, we help as many people as we can to secure their right to good health.

cMp believes in doing innovation & differentiation, in order to meet our customers need we have developed a huge basket of healthcare products which is addressing all the therapeutic dosage forms like tablets, capsules, syrups, injections, ointments, protein granules & herbal products. Alleviation of the sufferings of mankind, availability of the medicines to all at affordable price without any discrimination and continued efforts to improve the quality of the medicines are our values and mission.

cMp is driven by the vision to achieve significant business in proprietary prescription products with a strong presence in the Indian pharma market. We at cMp never compromise when it comes to quality of a product and constantly work towards satisfying the needs of the customer. Our passion for quality goes beyond business!

We are coming up with an R & D centre at Solan, Himachal Pradesh. cMp is eyeing upon better health achievement through effective and safe medicines based on technological innovation. Achieving customer satisfaction is fundamental to our business. The activity profile will include: Contract Research, Formulation Development, Bio-equivalence Studies, New Drug Delivery System.